K2N-93768-69921 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-22
Dose 1 — Pfizer-BioNTech
2021-02-12
Registered in v-safe
2021-02-12
Dose 2 — Pfizer-BioNTech
2021-02-13
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to do your normal daily activities

Adult check-in
2021-02-13
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-02-14
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Nausea

Adult check-in
2021-02-21
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2022-02-12
Survey response — 12 months, dose 2
MedDRA: Anosmia, Parosmia — Feeling: Fair

Free text: Asonomia unable to smell, everything that stinks smells sweet to me

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-22	Pfizer-BioNTech
2	2021-02-12	Pfizer-BioNTech

Call center

1 call center case

1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 11 — 12 months, dose 2

2022-02-12

Symptoms: Asonomia unable to smell, everything that stinks smells sweet to me

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Anosmia	·	·	✓
SD	Parosmia	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release